Abstract Title:

Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (Review).

Abstract Source:

Oncol Rep. 2021 Apr ;45(4):1-10. Epub 2021 Mar 2. PMID: 33649861

Abstract Author(s):

Haibo Zhang, Song Park, Hai Huang, Eungyung Kim, Junkoo Yi, Seong-Kyoon Choi, Zaeyoung Ryoo, Myoungok Kim

Article Affiliation:

Haibo Zhang


Ginsenoside Rh2 (G‑Rh2) is a natural bioactive product derived fromMeyer (). G‑Rh2 exhibits anticancer activity in various human cancer cell lines bothandby modulating several signaling pathways, such as those of PDZ‑binding kinase/T‑LAK cell‑originated protein kinase, phosphatidylinositol 3‑kinase, protein kinase B, mammalian target of rapamycin, epidermal growth factor receptor, p53, and reactive oxygen species. Moreover, G‑Rh2 could effectively reverse drug resistance and enhance therapeutic effects in cancer therapy. This review summarizes the chemical properties,andanticancer activity, and underlying molecular mechanisms of G‑Rh2 to facilitate cancer chemoprevention studies.

Print Options

Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.